Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load-Reference-Cited by-同舟云学术

Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load

Published:2019-05-01 Issue:5 Volume:13 Page:e0006967
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Haziot Michel E.,Gascon M. Rita,Assone Tatiane,Fonseca Luiz Augusto M.,Luiz Olinda do Carmo,Smid Jerusa,Paiva Arthur M.,Marcusso Rosa Maria do N.,de Oliveira A. C. Penalva,Casseb Jorge^ORCID

Funder

FAPESP

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference23 articles.

1. [Tropical spastic paraparesis in Martinique. High prevalence of anti-HTLV-I antibodies];JC Vernant;Presse Med,1986

2. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I);RF Edlich;J Emerg Med,2000

3. Epidemiological Aspects and World Distribution of HTLV-1 Infection;A Gessain;Front Microbiol,2012

4. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis;A Gessain;Lancet,1985

5. An HTLV-I carrier with Graves' disease followed by uveitis: isolation of HTLV-I from thyroid tissue;I Kubonishi;Int J Hematol,1997

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London Experience;Pathogens;2024-07-01

2. Impact and economic analysis of human T-cell lymphotropic virus type 1 (HTLV-1)-targeted antenatal screening, England and Wales, 2021;Eurosurveillance;2024-05-30

3. Induction of tolerogenicity following a molecular dialogue between HTLV-1-infected T cells and dendritic cells;2024-05-27

4. Peculiar transcriptional reprogramming with functional impairment of dendritic cells upon exposure to transformed HTLV-1-infected cells;2024-05-21

5. HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients;Pathogens;2024-05-13